Amprius Technologies Completes $100 Million ATM Equity Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 12 2026
0mins
Source: Newsfilter
- Successful Financing: Amprius has successfully issued 25.5 million shares under its ATM equity offering program initiated on October 2, raising approximately $97.5 million in net proceeds, significantly enhancing the company's financial strength.
- Sales Performance: As of December 31, 2025, Amprius sold shares at an average price of $11.17 per share, generating about $19.6 million in net proceeds over three months, indicating strong market demand for its products.
- Cash Reserves: The company's unaudited cash and cash equivalents stood at approximately $91.9 million as of December 31, 2025, providing ample funding support for future R&D and expansion efforts.
- Technological Edge: Amprius is renowned for its high-energy density lithium-ion batteries, achieving energy densities of up to 520 Wh/kg and 1,150 Wh/L, further solidifying its leadership position in the battery industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AMPX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AMPX
Wall Street analysts forecast AMPX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMPX is 17.17 USD with a low forecast of 16.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.580
Low
16.00
Averages
17.17
High
20.00
Current: 13.580
Low
16.00
Averages
17.17
High
20.00
About AMPX
Amprius Technologies, Inc. develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The Company’s commercially available SiMaxx batteries deliver up to 450 Wh/kg and 1,150 Wh/L, with third-party validation of 500 Wh/kg and 1,300 Wh/L. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems (UAS), such as drones and high-altitude pseudo satellites (HAPS). It offers high-performance silicon anode batteries under product platforms: SiCore and SiMaxx. Its SiCore batteries are based on an innovative, proprietary silicon anode material system delivering high-energy-density silicon anode batteries that surpass current graphite cell performance. Its SiMaxx high-energy battery cells are designed to maximize specific energy for applications with low power requirements.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wall Street Analysts Adjust Ratings
- Rating Changes Overview: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these companies.
- Market Impact: The changes in analysts' ratings could influence investor decisions, particularly for those considering buying SBET stock, highlighting the importance of understanding these ratings.
- Information Source: A complete view of all analyst rating changes can be found on Benzinga's analyst ratings page, offering a comprehensive market perspective.
- Investment Advice: While Benzinga provides market data, it does not offer specific investment advice, leaving investors to assess risks and rewards independently.
Continue Reading
Cigna Group (CI) Options Volume Hits 7,668 Contracts, Nearly 50% of Daily Average
- Active Options Trading: Cigna Group's options trading volume reached 7,668 contracts, equivalent to approximately 766,800 shares, representing nearly 49.8% of its average daily trading volume of 1.5 million shares over the past month, indicating heightened market interest in the stock.
- High Volume Insights: Notably, the $240 strike put option saw 2,622 contracts traded today, representing about 262,200 underlying shares, reflecting investor expectations of potential price declines, which could impact market sentiment towards Cigna.
- Visa Options Activity: Visa Inc's options volume stood at 30,071 contracts, translating to approximately 3.0 million shares, which is 47% of its average daily trading volume of 6.4 million shares over the past month, showcasing strong investor interest in Visa.
- Market Trend Analysis: Particularly, the $350 strike call option recorded a trading volume of 2,002 contracts today, representing around 200,200 underlying shares, indicating market confidence in Visa's potential price increase, which may influence its stock price trajectory.
Continue Reading